BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28861674)

  • 1. [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
    Kötter I; Stübiger N; Deuter C
    Z Rheumatol; 2017 Oct; 76(8):673-681. PubMed ID: 28861674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views.
    Clavel G; Gabison E; Semerano L
    Joint Bone Spine; 2019 Nov; 86(6):699-705. PubMed ID: 30711694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vision disorders in inflammatory-rheumatic diseases].
    Bernauer W
    Ther Umsch; 1996 Jan; 53(1):58-67. PubMed ID: 8650624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis.
    Turk MA; Hayworth JL; Nevskaya T; Pope JE
    J Rheumatol; 2021 Jan; 48(1):25-34. PubMed ID: 32358156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular inflammatory diseases associated with rheumatoid arthritis.
    Artifoni M; Rothschild PR; Brézin A; Guillevin L; Puéchal X
    Nat Rev Rheumatol; 2014 Feb; 10(2):108-16. PubMed ID: 24323074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diseases of the outer eye in rheumatoid arthritis].
    Feist E; Pleyer U
    Z Rheumatol; 2010 Jul; 69(5):403-10. PubMed ID: 20559644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The ocular manifestations in rheumatoid polyarthritis].
    Koos MJ; Suşan L; Muntean A; Lehaci C
    Oftalmologia; 1999; 46(1):15-20. PubMed ID: 10641082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems associated with treating ocular disease in underlying inflammatory rheumatic disease].
    Zierhut M; Kötter I; Lorenz HM
    Z Rheumatol; 2010 Jul; 69(5):393-6. PubMed ID: 20577747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations of rheumatoid arthritis.
    Reddy AK; Kolfenbach JR; Palestine AG
    Curr Opin Ophthalmol; 2022 Nov; 33(6):551-556. PubMed ID: 36165413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity.
    Matsuo T; Kono R; Matsuo N; Ezawa K; Natsumeda M; Soda K; Ezawa H
    Scand J Rheumatol; 1997; 26(2):113-6. PubMed ID: 9137326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ophthalmological involvement in rheumatic disease].
    Cojocaru VM; Ciurtin C; Pop M; Tomi A; Grecu P
    Oftalmologia; 2006; 50(2):56-61. PubMed ID: 16927760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory conditions of the eye associated with rheumatic diseases.
    Afshari NA; Afshari MA; Foster CS
    Curr Rheumatol Rep; 2001 Oct; 3(5):453-8. PubMed ID: 11564378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vasculitis in rheumatic diseases: an unseen burden.
    Androudi S; Dastiridou A; Symeonidis C; Kump L; Praidou A; Brazitikos P; Kurup SK
    Clin Rheumatol; 2013 Jan; 32(1):7-13. PubMed ID: 22955636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population.
    Levitt AE; McManus KT; McClellan AL; Davis JL; Goldhardt R; Galor A
    Cornea; 2015 Jul; 34(7):762-7. PubMed ID: 26053887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the field of rheumatic and collagen diseases].
    Dimitriu CG; Nestor R
    Med Interna (Bucur); 1972 Jul; 24(7):785-92. PubMed ID: 4263092
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular manifestations of the potentially lethal rheumatologic and vasculitic disorders.
    Foster CS
    J Fr Ophtalmol; 2013 Jun; 36(6):526-32. PubMed ID: 23688612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC; Ribi C; Guex-Crosier Y
    Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of corticosteroid agents in connective tissue disorders.
    Barraclough D
    Med J Aust; 1986 Apr; 144(8):427-32. PubMed ID: 2870416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.